Intel Capital Makes Investment in U.K.-Based Epichem

London -- Epichem, a U.K.-based provider of chemicals to the
semiconductor industry, announced that it has received an undisclosed
amount of venture-capital financing from Intel Capital. Intel was the
sole investor in the round, hitherto Epichem's first. Epichem said the
funds would allow it to expand R&D and manufacturing capabilities in
Taiwan, the U.K. and the U.S. "Epichem's extensive in-house technical
expertise, as well as its strong links to key academic centres in the U.K.
and (U.S.), continues to be a great advantage," said Epichem CEO
Barry Leese. "This funding by Intel Capital will help to ensure that
Epichem can solve some of the challenges presented by Moore's Law
to meet the manufacturing requirements for future-generation devices."
http://www.epichem.com/
http://www.intel.com/capital/